✦ LIBER ✦

Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly

✍ Scribed by D. REINEL; C. CLARKE

Book ID: 108692061
Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 485 KB
Volume: 17
Category: Article
ISSN: 0307-6938
DOI: 10.1111/j.1365-2230.1992.tb00278.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicentre, randomized, controlled st

A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement

✍ R. Baran; B. Sigurgeirsson; D. de Berker; R. Kaufmann; M. Lecha; J. Faergemann; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 949 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi

Rationale of frequency of use of ciclopi

Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: Results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage

✍ Dietrich Abeck; on behalf of the Loprox Shampoo Dosing Study Group 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB